Using nanotechnology to improve kidney disease treatments
Official title: Biomedical Resource Core
Funded at Northwestern University at Chicago · NIH-10914912 · Data updated 2026-11-12
This study is exploring new tiny technologies to help doctors better understand and treat kidney diseases, so patients can look forward to improved treatment options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $203,091 |
| NIH project number | 5U54DK137516-02 |
| Project ID | NIH-10914912 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from various kidney diseases who may benefit from innovative treatment approaches.
✕Less likely to help
Patients with non-kidney related conditions or those who do not have access to the resources provided by this research may not receive any benefit.
What this research studies
This research focuses on leveraging innovations in nanotechnology to enhance the understanding and treatment of kidney diseases. By utilizing advanced tools and platforms, the project aims to overcome traditional limitations in kidney research, allowing for better analysis of tissue function and cellular characteristics. The initiative is based at Northwestern University, where experts in nanomedicine will provide resources and support to kidney researchers, facilitating the development of more effective therapies. Patients may benefit from improved treatment options as a result of this collaborative effort.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for kidney diseases, improving patient outcomes.
How similar studies have gone: Other research has shown success in using nanotechnology for medical advancements, particularly in areas like oncology and vaccine development, indicating a promising potential for similar approaches in kidney disease.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Scott, Evan Alexander — Northwestern University at Chicago
- Study coordinator: Scott, Evan Alexander
Related research
Other NIH-funded projects on the same topics.
-
High-intensity exercise as a treatment for Parkinson's disease
This study is looking at whether doing high-intensity endurance exercise can help people who have just been diagnosed with Parkinson's disease feel better and slow down their symptoms, especially since current medications don't always do the trick.
-
Software to quickly assess organ dose after radionuclide exposure
This study is creating a helpful software tool that quickly calculates how much radiation your organs absorb after you've taken certain radioactive substances, so you can get better care and treatment based on your individual needs.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for better ways to improve your care and treatment, so you can get more personalized options that work best for you.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for new ways to improve care and treatment for patients, and if you join, you might help test some exciting new methods that could lead to better health for everyone.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for ways to improve care and treatment for patients like you, by trying out new methods that could help manage your health better.
-
Investigating core biological processes
This study is all about exploring important biological processes that affect our health, and it invites patients to help discover new ways to improve care for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.